The Role of Aha1 in Cancer and Neurodegeneration
Author Information
Author(s): Blagg Brian S.J., Catalfano Kevin C.
Primary Institution: Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN, United States
Hypothesis
Aha1 plays a critical role in the progression of cancer and neurodegenerative diseases through its interaction with Hsp90.
Conclusion
Aha1 is implicated in various disease states, including cancer and neurodegeneration, and disrupting the Hsp90/Aha1 complex may provide therapeutic benefits.
Supporting Evidence
- Aha1 is overexpressed in various cancers and is associated with poor patient outcomes.
- Disruption of the Hsp90/Aha1 complex has shown potential as a therapeutic strategy in cancer and neurodegenerative diseases.
- Aha1 enhances the maturation of client proteins that are critical for cancer cell proliferation and survival.
- Studies indicate that Aha1 levels correlate with the severity of neurodegenerative diseases like Alzheimer's.
Takeaway
Aha1 helps proteins in our body work properly, and when it doesn't, it can lead to diseases like cancer and Alzheimer's. Scientists are looking for ways to fix this.
Methodology
This review summarizes recent advances regarding the role of Aha1 in cancer and neurodegeneration, focusing on its interactions with Hsp90 and the development of small molecule disruptors.
Limitations
The review primarily discusses findings from various studies without original experimental data.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website